Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Davida F. Kruger"'
Publikováno v:
Clinical Diabetes. 41:198-207
Advances in insulin delivery technologies have led to the development of tubeless “patch” systems; however, these devices still involve a level of complexity. We surveyed individuals with type 1 or type 2 diabetes to explore their attitudes and s
Publikováno v:
Clin Diabetes
Publikováno v:
ADCES in Practice. 10:20-25
Autor:
Gregory P. Forlenza, Carol J. Levy, Rodolfo J. Galindo, Janet B. McGill, Guillermo E. Umpierrez, Anders L. Carlson, Christopher G. Parkin, Grazia Aleppo, Davida F. Kruger
Publikováno v:
Diabetes Technology & Therapeutics
Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid S
Autor:
William Biggs, Ian Orozco, Georgia Davis, Katrina J. Ruedy, Roy W. Beck, Janet B. McGill, Anuj Bhargava, Davida F. Kruger, Grazia Aleppo, William H. Polonsky, Quang T Nguyen, Laura A. Young, David Price, John B. Buse, Shichun Bao, Ryan Bailey, Peter Calhoun, Guillermo E. Umpierrez, Rodica Pop-Busui, Athena Philis-Tsimikas, K. Jean Lucas, Thomas W. Martens, Richard M. Bergenstal, Anne L. Peters
Publikováno v:
Diabetes Care
OBJECTIVE To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. RESEARCH DESIGN AND METHODS This multicenter trial had an initial
Autor:
Christopher G. Parkin, Guillermo E. Umpierrez, Carol J. Levy, Grazia Aleppo, Davida F. Kruger, Janet B. McGill, Rodolfo J. Galindo, Anders L. Carlson
Publikováno v:
Diabetes Technology & Therapeutics
Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Servic
Autor:
Rodolfo J. Galindo, Grazia Aleppo, Christopher G. Parkin, David A. Baidal, Anders L. Carlson, Eda Cengiz, Gregory P. Forlenza, Davida F. Kruger, Carol Levy, Janet B. McGill, Guillermo E. Umpierrez
Publikováno v:
Journal of Diabetes Science and Technology. :193229682211440
Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) and type 2 diabetes (T2D) populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Med
Autor:
Pamela R. Kushner, Davida F. Kruger
Publikováno v:
Clin Diabetes
Continuous glucose monitoring (CGM) provides comprehensive assessment of daily glucose measurements for patients with diabetes and can reveal high and low blood glucose values that may occur even when a patient’s A1C is adequately controlled. Among
Autor:
Sherwin C D'Souza, Davida F. Kruger
Publikováno v:
Diabetes Therapy
With the availability of second-generation basal insulin analogs, insulin degludec (100 and 200 units/ml [degludec]) and insulin glargine 300 units/ml (glargine U300), clinicians now have long-acting, efficacious treatment options with stable pharmac
Autor:
Alandra Verdejo, Maria J. Redondo, Michael R. Rickels, Ashley M. Butler, Jeffrey S. Gonzalez, Judith A. Long, Shivani Agarwal, Robin L. Gal, Davida F. Kruger, Viral N. Shah, Steven M Willi, Ashby F. Walker, Lauren Kanapka, Jennifer K. Raymond, Andrea Gerard-Gonzalez
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
ContextMinority young adults (YA) currently represent the largest growing population with type 1 diabetes (T1D) and experience very poor outcomes. Modifiable drivers of disparities need to be identified, but are not well-studied.ObjectiveTo describe